AstraZeneca&#39;s Crestor May Harm Kidneys
100059
Twenty-nine patients who took AstraZeneca Plc&#39;s AZN.L AZN.N anti-cholesterol drug Crestor have developed kidney damage, a US consumer group said on Friday as it called again for a ban on the medicine.
728615
Fifteen percent of patients who took  Sutent, a pill used to treat kidney and stomach cancers,  developed heart failure, U.S. researchers reported on  Wednesday.
356288
By Rosie Murray-West, City Correspondent (Filed: 14/09/2004). Astrazeneca shares plummeted yesterday as investors and analysts digested the pharmaceutical giant&#39;s announcement over potential blockbuster drug Exanta.
143479
AstraZeneca Plc's cholesterol-lowering  drug Crestor performed better than Pfizer Inc's Lipitor in an  AstraZeneca-funded study of patients with metabolic syndrome,  according to results released on Monday.
287525
The FDA has asked makers of Crestor to stop publishing an ad aimed at patients. The FDA sent a letter to Astra Zeneca on 21st December saying it was concerned that the ad may play down the risks associated with Crestor.
92784
Pfizer, AstraZeneca and Eli Lilly - each disclosed serious problems with important medicines yesterday, throwing a spotlight on the fact that the $500 billion
77441
AstraZeneca, Bristol-Myers Squibb and Schering-Plough must pay damages for overcharging on certain drugs.
179939
AstraZeneca&#39;s newest advertisements for its cholesterol-lowering drug Crestor are misleading and should be pulled from the market, consumer group Public Citizen says.
431734
Drug manufacturer AstraZeneca PLC announced Friday that trials of its new lung cancer drug found it didn't help patients live longer. Its shares dropped more than 8 percent.
136784
Shire Pharmaceuticals, Britain&#39;s third-biggest drugmaker, has won US regulatory approval for its long-delayed Fosrenol treatment for severe kidney disease.
547717
BASEL, Switzerland, August 30 /PRNewswire/ -- Novartis Pharma AG has received an &quot;approvable&quot; letter from the US Food and Drug Administration (FDA) for Certican (everolimus) in combination with Neoral (ciclosporin for microemulsion) for the prevention of
564304
WASHINGTON/LONDON  - An FDA review AstraZeneca  Plc's  under the name Coumadin.
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival
333419
AstraZeneca's advertisements defending Crestor were criticized in part because concerns remain about the drug's safety.
52228
Drug maker AstraZeneca Plc  AZN.L on Thursday said it has sued generic drug maker  KV Pharmaceutical Co KVa.N over one of its branded high blood  pressure medications.
47264
Many dialysis patients get too much of the drug Epogen, a problem that not only may harm some patients but leads to the wasteful spending of hundreds of millions of dollars a year, a House committee was told Wednesday.
466698
Swiss drug maker Novartis Pharma AG said Monday that the Food and Drug Administration has again requested more information on the company&#39;s Certican treatment, when used in combination with Neoral, to prevent heart and kidney transplant rejection episodes